Sirio Pharma Co., Ltd. (300791.SZ)
CNY 25.0
(2.38%)
CNY 25.0
(2.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.58 Billion | 2.5 Billion | 2.36 Billion | 2.06 Billion | 1.57 Billion | 1.59 Billion |
| Cost of Revenue | 2.49 Billion | 1.72 Billion | 1.59 Billion | 1.39 Billion | 1.05 Billion | 1.04 Billion |
| Gross Profit | 1.08 Billion | 781.7 Million | 775.21 Million | 673.8 Million | 520.37 Million | 552.99 Million |
| Operating Expenses | 795.88 Million | 522.4 Million | 480.32 Million | 368.99 Million | 358.56 Million | 299.29 Million |
| Selling, General and Administrative Expenses | 626.88 Million | 273.64 Million | 223.22 Million | 187.59 Million | 186.24 Million | 146.27 Million |
| Research and Development Expenses | 110.49 Million | 80.71 Million | 83.19 Million | 64.71 Million | 65.78 Million | 62.06 Million |
| Other Expenses | 58.5 Million | -13.53 Million | -8.91 Million | -3.19 Million | 4.74 Million | 2.14 Million |
| Cost and Expenses | 3.29 Billion | 2.24 Billion | 2.07 Billion | 1.76 Billion | 1.41 Billion | 1.34 Billion |
| Operating Income | 282.02 Million | 265.05 Million | 289.81 Million | 315.61 Million | 151.69 Million | 228.23 Million |
| Interest Expense | 61.85 Million | 42.77 Million | 13.92 Million | 1.8 Million | 13.8 Million | 13.29 Million |
| Income Tax Expense | 32.96 Million | 39.23 Million | 49.06 Million | 54.59 Million | 14.37 Million | 27.15 Million |
| Earnings before Tax | 273.25 Million | 251.51 Million | 280.9 Million | 311.96 Million | 156.89 Million | 230.38 Million |
| Net Income | 281.03 Million | 212.28 Million | 231.83 Million | 257.36 Million | 142.52 Million | 203.22 Million |
| Earnings Per Share Basic | 1.56 | 1.18 | 1.29 | 1.43 | 0.79 | 1.51 |
| Earnings Per Share Diluted | 1.56 | 1.17 | 1.29 | 1.43 | 0.79 | 1.51 |
| Weighted Average Shares Outstanding | 180.32 Million | 180.49 Million | 180.16 Million | 180 Million | 179.99 Million | 134.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 180.32 Million | 181.79 Million | 180.16 Million | 180 Million | 179.99 Million | 134.88 Million |
| Gross Margin | 0.30 | 0.31 | 0.33 | 0.33 | 0.33 | 0.35 |
| EBIT Margin | 0.17 | 0.17 | 0.17 | 0.19 | 0.15 | 0.20 |
| Profit Margin | 0.08 | 0.08 | 0.10 | 0.12 | 0.09 | 0.13 |
| EBITDA | 592.07 Million | 432.13 Million | 402.67 Million | 396.64 Million | 247.02 Million | 299.57 Million |
| Earnings Before Tax Margin | 0.08 | 0.11 | 0.12 | 0.15 | 0.10 | 0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.05 Billion | 1.03 Billion | 951.5 Million | 1.07 Billion | 3.58 Billion | 958.07 Million |
| Cost of Revenue | 744.49 Million | 709.17 Million | 660.17 Million | 749.63 Million | 2.49 Billion | 658.41 Million |
| Gross Profit | 313.48 Million | 323.43 Million | 291.33 Million | 329.46 Million | 1.08 Billion | 299.65 Million |
| Operating Expenses | 212.25 Million | 207.8 Million | 199.04 Million | 177.9 Million | 689.58 Million | 182.64 Million |
| Selling, General and Administrative Expenses | 401.57 Million | 173.36 Million | 165.05 Million | -45.81 Million | - | 269.19 Million |
| Research and Development Expenses | 31.33 Million | 33.77 Million | 30.79 Million | 35.02 Million | - | 28.97 Million |
| Other Expenses | -220.65 Million | -662.56 Thousand | -3.58 Million | -11.33 Million | -12.15 Million | 5.88 Million |
| Cost and Expenses | 956.74 Million | 916.98 Million | 859.22 Million | 927.54 Million | 3.18 Billion | 841.06 Million |
| Operating Income | 74.11 Million | 115.62 Million | 72.91 Million | 84.46 Million | 282.02 Million | 94.62 Million |
| Interest Expense | 27.43 Million | 28.15 Million | 17.79 Million | 28.47 Million | 78.47 Million | 17.97 Million |
| Income Tax Expense | -3.04 Million | 16.81 Million | 15.45 Million | -4.06 Million | 32.96 Million | 14.22 Million |
| Earnings before Tax | 73.76 Million | 98.86 Million | 69.32 Million | 76.52 Million | 273.25 Million | 93.98 Million |
| Net Income | 85.32 Million | 91.44 Million | 63.02 Million | 95.89 Million | 281.03 Million | 83.96 Million |
| Earnings Per Share Basic | 0.37 | 0.51 | 0.35 | 0.53 | - | 0.47 |
| Earnings Per Share Diluted | 0.37 | 0.51 | 0.35 | 0.53 | - | 0.47 |
| Weighted Average Shares Outstanding | 233.27 Million | 179.7 Million | 181.53 Million | 179.99 Million | 180.32 Million | 180.49 Million |
| Weighted Average Shares Outstanding (Diluted) | 233.27 Million | 179.7 Million | 181.53 Million | 179.99 Million | 180.32 Million | 180.49 Million |
| Gross Margin | 0.30 | 0.31 | 0.31 | 0.31 | 0.30 | 0.31 |
| EBIT Margin | 0.10 | 0.18 | 0.09 | 0.14 | - | 0.13 |
| Profit Margin | 0.08 | 0.09 | 0.07 | 0.09 | 0.08 | 0.09 |
| EBITDA | 101.2 Million | 185.36 Million | 85.54 Million | 149.94 Million | - | 125.8 Million |
| Earnings Before Tax Margin | 0.07 | 0.11 | 0.08 | 0.08 | 0.08 | 0.10 |
NPR
PEY
CZNL
300815
000518
PVH